CALT acquired by Japan’s Asahi Kasei for $39.26/ADS (SEK 416)—a $74% premium to Friday’s closing price on Nasdaq: https://finance.yahoo.com/news/asahi-kasei-buy-swedish-biotech-091328729.html The nominal deal value is $1.1B (SEK 11.8B).